Hormones and breast cancer: Evidence and implications for consideration of risks and benefits of hormone replacement therapy

Keyphrases

• Association Strength 16%
• Benefit-risk Trade-offs 16%
• Biological Mechanisms 16%
• Biological Plausibility 16%
• Breast Cancer 100%
• Breast Cancer Mortality 16%
• Breast Cancer Risk 83%
• Breast Cancer Support 16%
• Cancer Causes 16%
• Causal Relations 66%
• Cell Proliferation 16%
• Counseling 16%
• Dose-response 16%
• Duration of Use 33%
• Endogenous Estrogens 16%
• Endogenous Hormone Levels 33%
• Epidemiologic Studies 16%
• Estrogen 16%
• Estrogen Replacement Therapy 16%
• Etiology 16%
• Evidence Support 16%
• Female Breast 16%
• Female Hormones 16%
• Heart Disease 16%
• Hormone Replacement Therapy 100%
• Increasing Risk 33%
• Menopausal Symptoms 16%
• Menopause 16%
• Oral Contraceptives 16%
• Osteoporosis Disease 16%
• Osteoporosis Prevention 16%
• Positive Relations 16%
• Postmenopausal Hormones 16%
• Postmenopausal Women 33%
• Progestin 16%
• Risk Factors for Cardiovascular Diseases 16%
• Short-term Use 16%
• Total Mortality 16%

Medicine and Dentistry

• Biological Product 18%
• Breast Cancer 100%
• Cancer Incidence 9%
• Cardiovascular Disease 9%
• Cell Proliferation 9%
• Cohort Effect 9%
• Counseling 9%
• Dose Response 9%
• Endogenous Hormone 18%
• Estrogen Therapy 9%
• Etiology of Breast Cancer 9%
• Gestagen 9%
• Heart Disease 9%
• Hormone Determination 18%
• Hormone Substitution 100%
• Malignant Neoplasm 18%
• Menopausal Symptom 9%
• Oral Contraceptive 9%
• Osteoporosis 9%
• Postmenopause 18%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Product 16%
• Breast Cancer 100%
• Cancer Incidence 8%
• Cardiovascular Disease 8%
• Epidemiology 8%
• Heart Disease 8%
• Malignant Neoplasm 16%
• Oral Contraceptive 8%
• Progestin 8%
• Replacement Therapy 100%